{
  "symbol": "AMGN",
  "year": 2024,
  "Period": "Q3",
  "report_type": "Q10",
  "metrics": {
    "mdna_sentiment": 0.0,
    "outlook_sentiment": 0.0831,
    "forward_ratio": 1.0,
    "hedge_ratio": 0.184
  },
  "top_positive": [
    {
      "sent": "21 Impact of hedging transactions The following tables summarize the amounts recorded in income and expense line items and the effects thereon from fair value and cash flow hedging, including discontinued hedging relationships (in millions): Three months ended March 31, 2024 Product sales Other (expense) income, net Interest expense, net Total amounts recorded in income and (expense) line items presented in the Condensed Consolidated Statements of (Loss) Income $ 7,118 $ ( 235 ) $ ( 824 ) The effects of cash flow and fair value hedging: Gains (losses) on cash flow hedging relationships reclassified out of AOCI: Foreign currency forward contracts $ 51 $ \u2014 $ \u2014 Cross-currency swap contracts $ \u2014 $ ( 31 ) $ \u2014 Gains (losses) on fair value hedging relationships\u2014interest rate swap agreements: Hedged items (1) $ \u2014 $ \u2014 $ 49 Derivatives designated as hedging instruments $ \u2014 $ \u2014 $ ( 28 ) Three months ended March 31, 2023 Product sales Other (expense) income, net Interest expense, net Total amounts recorded in income and (expense) line items presented in the Condensed Consolidated Statements of (Loss) Income $ 5,846 $ 2,064 $ ( 543 ) The effects of cash flow and fair value hedging: Gains (losses) on cash flow hedging relationships reclassified out of AOCI: Foreign currency forward contracts $ 52 $ \u2014 $ \u2014 Cross-currency swap contracts $ \u2014 $ ( 22 ) $ \u2014 (Losses) gains on fair value hedging relationships\u2014interest rate swap agreements: Hedged items (1) $ \u2014 $ \u2014 $ ( 88 ) Derivatives designated as hedging instruments $ \u2014 $ \u2014 $ 114 __________ (1) Gains on hedged items do not exactly offset losses on the related designated hedging instruments due to amortization of the cumulative amounts of fair value hedging adjustments included in the carrying amount of the hedged debt for discontinued hedging relationships and the recognition of gains on terminated hedges when the corresponding hedged item was paid down in the period.",
      "score": 0.9924
    },
    {
      "sent": "In addition, our revolving credit agreement and term loan credit agreement include a financial covenant that requires us to maintain a specified minimum interest coverage ratio of (i) the sum of consolidated net income, interest expense, provision for income taxes, depreciation expense, amortization expense, unusual or nonrecurring charges and other noncash items (consolidated earnings before interest, taxes, depreciation and amortization) to (ii) Consolidated Interest Expense, each as defined and described in the respective agreements.",
      "score": 0.9776
    },
    {
      "sent": "In addition, our revolving credit agreement and term loan credit agreement include a financial covenant that requires us to maintain a specified minimum interest coverage ratio of (i) the sum of consolidated net income, interest expense, provision for income taxes, depreciation expense, amortization expense, unusual or nonrecurring charges and other noncash items (consolidated earnings before interest, taxes, depreciation and amortization) to (ii) Consolidated Interest Expense, each as defined and described in the respective agreements.",
      "score": 0.9776
    }
  ],
  "top_negative": [
    {
      "sent": "Among the reasons we may be unable to obtain these raw materials, medical devices and components include: \u2022 regulatory requirements or action by regulatory agencies or others; \u2022 adverse financial or other strategic developments at or affecting the supplier, including bankruptcy; \u2022 unexpected demand for or shortage of raw materials, medical devices or components; \u2022 failure to comply with our quality standards which results in quality and product failures, complaints, product contamination and/or recall; \u2022 a material shortage, contamination, recall and/or restrictions on the use of certain biologically derived substances or other raw materials; \u2022 discovery of previously unknown or undetected imperfections in raw materials, medical devices or components; \u2022 cyberattacks on supplier systems; \u2022 natural or other disasters, including hurricanes, earthquakes, volcanoes or fires; \u2022 labor disputes (such as strikes) or shortages, including from the effects of health emergencies (such as novel viruses or pandemics) or natural disasters; and \u2022 geopolitical conflicts (such as the ongoing conflicts in Ukraine and the Middle East).",
      "score": -0.967
    },
    {
      "sent": "Even though we continue to invest in the monitoring, protection and resilience of our critical and/or sensitive data and systems, there can be no assurances that our efforts will detect, prevent or fully recover systems or data from all breakdowns, service interruptions, attacks and/or breaches of our systems that could adversely affect our business and operations and/or result in the loss or exposure of critical, proprietary, private, confidential or otherwise sensitive data, which could result in material financial, legal business or reputational harm to us or negatively affect our stock price.",
      "score": -0.9325
    },
    {
      "sent": "Even though we continue to invest in the monitoring, protection and resilience of our critical and/or sensitive data and systems, there can be no assurances that our efforts will detect, prevent or fully recover systems or data from all breakdowns, service interruptions, attacks and/or breaches of our systems that could adversely affect our business and operations and/or result in the loss or exposure of critical, proprietary, private, confidential or otherwise sensitive data, which could result in material financial, legal business or reputational harm to us or negatively affect our stock price.",
      "score": -0.9325
    }
  ],
  "forward_snippets": [
    "We continue to believe our accrual for income tax liabilities is appropriate based on past experience, interpretations of tax law, application of the tax law to our facts and judgments about potential actions by tax authorities; however, due to the complexity of the provision for income taxes and uncertain resolution of these matters, the ultimate outcome of any tax matters may result in payments substantially greater than amounts accrued and could have a material adverse impact on our condensed consolidated financial statements.",
    "We believe the fair value option best reflects the economics of the underlying transaction.",
    "We describe our legal proceedings and other matters that are significant or that we believe could become significant in this footnote; and in Note 20, Contingencies and commitments, to the consolidated financial statements in our Annual Report on Form 10-K for the year ended December 31, 2023.",
    "Such words as \u201cexpect,\u201d \u201canticipate,\u201d \u201coutlook,\u201d \u201ccould,\u201d \u201ctarget,\u201d \u201cproject,\u201d \u201cintend,\u201d \u201cplan,\u201d \u201cbelieve,\u201d \u201cseek,\u201d \u201cestimate,\u201d \u201cshould,\u201d \u201cmay,\u201d \u201cassume\u201d and \u201ccontinue\u201d as well as variations of such words and similar expressions are intended to identify such forward-looking statements.",
    "Our robust pipeline includes potential first-in-class medicines at all stages of development."
  ],
  "curated_text": "Symbol: AMGN. Year: 2024. Period: Q3. ReportType: Q10. Section: Management Discussion and Analysis (MD&A). Key metrics include sentiment, forward outlook, and risk hedging.  Top positive sentences: 21 Impact of hedging transactions The following tables summarize the amounts recorded in income and expense line items and the effects thereon from fair value and cash flow hedging, including discontinued hedging relationships (in millions): Three months ended March 31, 2024 Product sales Other (expense) income, net Interest expense, net Total amounts recorded in income and (expense) line items presented in the Condensed Consolidated Statements of (Loss) Income $ 7,118 $ ( 235 ) $ ( 824 ) The effects of cash flow and fair value hedging: Gains (losses) on cash flow hedging relationships reclassified out of AOCI: Foreign currency forward contracts $ 51 $ \u2014 $ \u2014 Cross-currency swap contracts $ \u2014 $ ( 31 ) $ \u2014 Gains (losses) on fair value hedging relationships\u2014interest rate swap agreements: Hedged items (1) $ \u2014 $ \u2014 $ 49 Derivatives designated as hedging instruments $ \u2014 $ \u2014 $ ( 28 ) Three months ended March 31, 2023 Product sales Other (expense) income, net Interest expense, net Total amounts recorded in income and (expense) line items presented in the Condensed Consolidated Statements of (Loss) Income $ 5,846 $ 2,064 $ ( 543 ) The effects of cash flow and fair value hedging: Gains (losses) on cash flow hedging relationships reclassified out of AOCI: Foreign currency forward contracts $ 52 $ \u2014 $ \u2014 Cross-currency swap contracts $ \u2014 $ ( 22 ) $ \u2014 (Losses) gains on fair value hedging relationships\u2014interest rate swap agreements: Hedged items (1) $ \u2014 $ \u2014 $ ( 88 ) Derivatives designated as hedging instruments $ \u2014 $ \u2014 $ 114 __________ (1) Gains on hedged items do not exactly offset losses on the related designated hedging instruments due to amortization of the cumulative amounts of fair value hedging adjustments included in the carrying amount of the hedged debt for discontinued hedging relationships and the recognition of gains on terminated hedges when the corresponding hedged item was paid down in the period. In addition, our revolving credit agreement and term loan credit agreement include a financial covenant that requires us to maintain a specified minimum interest coverage ratio of (i) the sum of consolidated net income, interest expense, provision for income taxes, depreciation expense, amortization expense, unusual or nonrecurring charges and other noncash items (consolidated earnings before interest, taxes, depreciation and amortization) to (ii) Consolidated Interest Expense, each as defined and described in the respective agreements. In addition, our revolving credit agreement and term loan credit agreement include a financial covenant that requires us to maintain a specified minimum interest coverage ratio of (i) the sum of consolidated net income, interest expense, provision for income taxes, depreciation expense, amortization expense, unusual or nonrecurring charges and other noncash items (consolidated earnings before interest, taxes, depreciation and amortization) to (ii) Consolidated Interest Expense, each as defined and described in the respective agreements. Top negative sentences: Among the reasons we may be unable to obtain these raw materials, medical devices and components include: \u2022 regulatory requirements or action by regulatory agencies or others; \u2022 adverse financial or other strategic developments at or affecting the supplier, including bankruptcy; \u2022 unexpected demand for or shortage of raw materials, medical devices or components; \u2022 failure to comply with our quality standards which results in quality and product failures, complaints, product contamination and/or recall; \u2022 a material shortage, contamination, recall and/or restrictions on the use of certain biologically derived substances or other raw materials; \u2022 discovery of previously unknown or undetected imperfections in raw materials, medical devices or components; \u2022 cyberattacks on supplier systems; \u2022 natural or other disasters, including hurricanes, earthquakes, volcanoes or fires; \u2022 labor disputes (such as strikes) or shortages, including from the effects of health emergencies (such as novel viruses or pandemics) or natural disasters; and \u2022 geopolitical conflicts (such as the ongoing conflicts in Ukraine and the Middle East). Even though we continue to invest in the monitoring, protection and resilience of our critical and/or sensitive data and systems, there can be no assurances that our efforts will detect, prevent or fully recover systems or data from all breakdowns, service interruptions, attacks and/or breaches of our systems that could adversely affect our business and operations and/or result in the loss or exposure of critical, proprietary, private, confidential or otherwise sensitive data, which could result in material financial, legal business or reputational harm to us or negatively affect our stock price. Even though we continue to invest in the monitoring, protection and resilience of our critical and/or sensitive data and systems, there can be no assurances that our efforts will detect, prevent or fully recover systems or data from all breakdowns, service interruptions, attacks and/or breaches of our systems that could adversely affect our business and operations and/or result in the loss or exposure of critical, proprietary, private, confidential or otherwise sensitive data, which could result in material financial, legal business or reputational harm to us or negatively affect our stock price. Forward-looking snippets: We continue to believe our accrual for income tax liabilities is appropriate based on past experience, interpretations of tax law, application of the tax law to our facts and judgments about potential actions by tax authorities; however, due to the complexity of the provision for income taxes and uncertain resolution of these matters, the ultimate outcome of any tax matters may result in payments substantially greater than amounts accrued and could have a material adverse impact on our condensed consolidated financial statements. We believe the fair value option best reflects the economics of the underlying transaction. We describe our legal proceedings and other matters that are significant or that we believe could become significant in this footnote; and in Note 20, Contingencies and commitments, to the consolidated financial statements in our Annual Report on Form 10-K for the year ended December 31, 2023. Such words as \u201cexpect,\u201d \u201canticipate,\u201d \u201coutlook,\u201d \u201ccould,\u201d \u201ctarget,\u201d \u201cproject,\u201d \u201cintend,\u201d \u201cplan,\u201d \u201cbelieve,\u201d \u201cseek,\u201d \u201cestimate,\u201d \u201cshould,\u201d \u201cmay,\u201d \u201cassume\u201d and \u201ccontinue\u201d as well as variations of such words and similar expressions are intended to identify such forward-looking statements. Our robust pipeline includes potential first-in-class medicines at all stages of development."
}